Navigation Links
XELR8 Holdings Announces Record First Quarter Revenue
Date:5/1/2008

r share $(0.05) $(0.13)

Weighted average common shares

outstanding, basic and diluted 15,334,533 10,753,350

XELR8 HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

Three Months Ended March 31, 2008 and 2007

2008 2007

Cash flows from operating activities:

Net income (loss) $(749,362) $(1,364,109)

Adjustments to reconcile

Depreciation and amortization 11,844 11,779

Stock and stock options issued

for services 275,375 474,912

Expense related to anti-dilution

of warrants 13,770 -

Loss on asset disposal 1,130 -

Interest expense and amortization

related to bridge loan financing - 428,889

Change in allowance for doubtful

accounts 1,848 2,368

Change in allowance for inventory

obsolescence (14,716) 81,450

Change in allowance for product

returns 10,092 30,866

Changes in assets and liabilities:

Accounts receivable 4,392 (4,052)

Inventory 94,736 (40,488)

Other current assets 3,808 79,511

Accounts payable and accrued

expenses 131,383 122,355

Net cash (used) by operating

activities (215,700)
'/>"/>

SOURCE XELR8 Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. XELR8 Holdings Announces Fiscal 2007 Financial Results
2. XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007
3. NightHawk Radiology Holdings, Inc. Announces Appointment of David Engert to the Board of Directors
4. InfuSystem Holdings Appoints Two New Board Members
5. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
6. Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
7. Zimmer Holdings, Inc. Reports First Quarter Financial Results
8. NightHawk Radiology Holdings, Inc. to Host Conference Call to Discuss First Quarter 2008 Earnings Results
9. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
10. Zimmer Holdings to Present at Morgan Stanley Healthcare Unplugged Conference
11. HMS Holdings Corp. Hosts First Quarter 2008 Financial Teleconference and Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...rst Walkathon to Benefit Muscular Dystrophy Resear...ugust 29, 2008 -- Students, faculty and staff from...I), in New Jersey, raised $11,000 for muscular dys...ek. Proceeds from the event are in support of loc... The all-volunteer event was attended by more than...
(Date:8/29/2008)...9 /PRNewswire/ --, - MYA Cosmetic Surgery Seems t... Stars but the big Question is who Will be Next?, ...d being on national,television for an hour each ni...the way you look. For many previous Big Brother co...the house contestants may undoubtedly spend,hours ...
(Date:8/29/2008)...D presents Telemedicine Encounter Management Syste...ations as a possible solution to national health c...ord, MA (PRWEB) August 29, 2008 -- If there has be...ers at the Democratic National Convention it has b...ational health care issues., , ,Our Democratic lea...
(Date:8/29/2008)...usted life science software provider allows federa...ia GSA. , Reston, VA (PRW... software engineering firm dedicated to the life s...vices Administration (GSA) Contract. The GSA IT Sc...bility to conveniently engage 5AM Solutions, softw...
Breaking Medicine News(10 mins):Health News:Sanford-Brown Institute - Iselin Raises $11,000 for Ryan's Quest 2Health News:MYA Makes Big Brother Stars Amazing! 2Health News:MYA Makes Big Brother Stars Amazing! 3Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2
... researchers say girls are affected more than boys...this difference between girls and boys being diagn...process of conducting a study which aims to establ... and why. The study included 307 healthy children ...
...risk factors may reduce the risk of dementia, say ... which shows that cardiovascular risk factors in m...ementia in old age. Risk factors for cardiovascul...ertension, diabetes and smoking. Each of these car...
...the only thing diabetics need to do to avoid the p...ay researchers based on findings of a recent study...ing, and high blood pressure, is found to exacerba...hers proper blood sugar control can markedly decre...
... researchers say weight gain after age 18 can be a...ostmenopausal women who // are not taking hormone ... nearly 62,000 women, ages 50 to 74, by asking the... current weight. Since then, the women have been p...
Other Medicine News:
(Date:8/26/2008)...- XTENT, Inc.,(Nasdaq: XTN...low-up data,from the CUSTOM II trial was published...rnal, EuroIntervention. The lead author of the art... Medical Center Utrecht, Utrecht,The Netherlands ...linical,sites across Europe., The one-year CUSTOM...
(Date:8/25/2008)...and Treatment Strategies--, PHILADELPHIA, Aug. 25...ered gene mutations that are the main cause of the...astoma. In addition, the researchers found,that th...isk forms of,non-inherited neuroblastoma, the more...bles us to offer the first genetic tests to famili...
(Date:8/25/2008)...reatment and Japanese Development Studies ...rk, August 25 /- Genmab has...ab in chronic lymphocytic,leukemia and non-Hodgkin...ay plans to begin four studies of,ofatumumab in ch...n-Hodgkin,s lymphoma (NHL) this year., "Genmab an...
(Date:8/21/2008)...paign Addresses Knowledge Gap, Educates, American...ant Choice to Make thi...- A new survey of parents of,eight-to-17-year olds...hings they believe they can do to help protect aga...uidelines state that getting an annual flu,vaccina...
Breaking Medicine Technology:XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 2Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 3Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 4Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 5Computer predicts anti cancer molecules 6024 1First semiconductor based PET scanner demonstrates potential to aid in early diagnosis of disease 6022 1First semiconductor based PET scanner demonstrates potential to aid in early diagnosis of disease 6022 2Michigan Tech scientist models molecular switch 6020 1Michigan Tech scientist models molecular switch 6020 2TalkAIDS 3A A 26PI Wellness Center Launches a New Anti Stigma Campaign With International Star Joan Chen 22007 1TalkAIDS 3A A 26PI Wellness Center Launches a New Anti Stigma Campaign With International Star Joan Chen 22007 2
...Spain--(BUSINESS WIRE)--Apr 11, 2007 - New data,su...X-950), one of,the most advanced investigational o...itis C virus (HCV) infection, will be presented,at...on for the,Study of the Liver (EASL) in Barcelona ...aprevir have been accepted for presentation,at the...
...SCO, April 11, 2007 /PRNewswire-FirstCall/ -- Vica...luenza vaccine,formulated with the company,s Vaxfe...ntibody responses than an unformulated vaccine,at ...e. Formulation,of sanofi pasteur,s Fluzone(R) comm...early 10-fold reduction in vaccine,dose while gene...
Other Medicine Technology:Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 2Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 3Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 4Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 5
Micro-throw grasping technology allows the grasper to open wider in a shorter length and permits close approximation to the stone. The Unidex handle facilitates easy, ergonomic one-handed operation.
Fulgurating Electrode, 3 F
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use.
...al MicroChoice® system is a set of 6 electric ...e®, PowerPro®, or E9000® consoles. Mic...the drilling, reaming, shaping and cutting of bone...dic surgery, Oral/Maxillofacial surgery, Facial Pl...
Medicine Products: